New wall motion abnormalities, potentially from myocarditis or acute coronary syndrome, showed a trend toward significance with tocilizumab treatment, but other arrhythmias and structural heart disease showed no significant changes with tocilizumab treatment.
← all excerpts
The cardiovascular effects of interleukin-6 inhibition in patients with severe coronavirus-19 infection.
2
—
—
The sentences
Other cardiac structural endpoints did not reach statistical significance.